Siegfried Holding AG
SFZN
Pozycja w akcjach
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Cena akcji
$88.34
Kapitalizacja rynkowa
$3.87B
Zmiana (1 dzień)
1.68%
Zmiana (1 rok)
-12.97%
Kraj
CH
Handel Siegfried Holding AG (SFZN)
Kategoria
Healthcare
EPS dla Siegfried Holding AG (SFZN)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Siegfried Holding AG, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Siegfried Holding AG od 2002 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2025 | $4.85 | 18.12% |
| 2024 | $4.11 | -87.02% |
| 2023 | $31.64 | -21.09% |
| 2022 | $40.10 | 60.83% |
| 2021 | $24.93 | 52.56% |
| 2020 | $16.34 | 23.03% |
| 2019 | $13.28 | -3.35% |
| 2018 | $13.74 | 30.30% |
| 2017 | $10.55 | 49.52% |
| 2016 | $7.05 | -28.70% |
| 2015 | $9.89 | -1.42% |
| 2014 | $10.04 | -40.57% |
| 2013 | $16.89 | 168.36% |
| 2012 | $6.29 | 123.93% |
| 2011 | $2.81 | -154.60% |
| 2010 | $-5.15 | -58.42% |
| 2009 | $-12.38 | -51.03% |
| 2008 | $-25.28 | -258.81% |
| 2007 | $15.92 | 65.86% |
| 2006 | $9.60 | -4.54% |
| 2005 | $10.05 | 90.16% |
| 2004 | $5.29 | -66.53% |
| 2003 | $15.80 | 5.55% |
| 2002 | $14.96 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
